Published by Coherent Market Insights
Posted on October 8, 2021
6 min readLast updated: January 30, 2026
The Gene Panel market is forecasted to grow significantly, reaching $29,975.8 Mn by 2028, driven by advancements in DNA sequencing and the impact of COVID-19.
The global Gene Panel market is expected to reach US$ 29,975.8 Mn by 2028 from US$ 22,044.7 Mn in 2021, at a CAGR of 20.2%. The base year considered for the study is 2020 and the forecast period 2021-2028.
Gene panels are specialized diagnostic tools used to assess multiple genes at once for mutations related to diseases such as cancer, cardiomyopathy, and others. Gene panels enable the users to obtain results at a reduced cost and time. Gene panels are useful in sequencing genes such as BRCA1 to detect mutations that may lead to cancer. DNA sample from blood, muscle or saliva can be used in gene panel testing. Low muscle tone, epilepsy, and short stature are few conditions which can be diagnosed using gene panel tests. Rapid research in DNA sequencing technology has led to the advancement of gene panels making them more efficient, economical, and flexible.
Request Sample Gene Panel market Report @
https://www.coherentmarketinsights.com/insight/request-sample/4545
The COVID-19 pandemic and lockdown in various countries across the globe have impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the biotechnology industry mainly due to strict lockdown in several regions. The coronavirus pandemic has impacted development, production, and supply of healthcare products and affected businesses of various companies operating in the healthcare sector across the globe. The pandemic has led to the closure of industrial establishments, except manufacturing of essential commodities, and disruption in supply chain of healthcare products.
However, the rising incidences of cardiovascular diseases, arthritis, and neurological diseases associated with COVID-19 infection are expected to have a positive impact on the market growth of gene panel, as gene panels can be used for the detection of such diseases. For instance, according to an article published by the JAMA Cardiology Journal in July 2020, a gene panel consisting of six pro-inflammatory genes was used to show that the activity of these genes was higher in heart of COVID-19 patients as compared to the COVID-19 negative population. According to an article published by the National Centers for Biotechnology Information in January 2021, a study conducted in Wuhan, China, revealed that out of 221 COVID-19 positive patients, approximately 5% had ischemic stroke and 0.5% had hemorrhagic stroke. In another study from the same region, out of 214 COVID-19 positive patients, about 5.7% people with severe COVID infection were reported with acute cerebrovascular disease.
Thus, impact of the coronavirus (COVID-19) pandemic is expected to aid the growth of the global gene panel market during the forecast period, owing to the need for reliable gene panels as a diagnostic tool for detection of comorbid diseases associated with COVID-19 infection.
Ask for PDF sample Gene Panel market report @
https://www.coherentmarketinsights.com/insight/request-pdf/4545
The objectives of this study are as follows:
To define, describe, and forecast the global Gene Panel market by product & service, technique, design, application, end user, and region
To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players
To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze competitive developments in the Gene Panel market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities
• Data regarding the industry share by every item fragment, alongside their reasonable worth, have been served in the report.
• We provide statistic information, strategic and analysis tool results to provide a sophisticated landscape and target key market players.
• Our report helps readers decipher the current and future constraints of the market and optimal business strategies to enhance market development.
• Our reports have been examined by professional experts of the industry, which makes them beneficial for the company to maximize their return on investment.
• The analysis acknowledges that the sector players & key drivers of both conflicts and growth assess the impact of limitations as well as the opportunities on the sector.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4545
Available Customizations
With the given market data, Coherent Market Insights offers customizations as per the company‘s specific needs.
The following customization options are available for this report.
This report segments the Gene Panel market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2020, the test kits segment accounted for the largest share of the total market. The growing demand for Gene Panel in research as well as diagnostics to understand the genetic variability of chronic disorders is propelling the growth of this Gene Panel market segment.
Based on design, the Gene Panel market is segmented into predesigned and customized panels. The customized Gene Panel segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
The Gene Panel market is fragmented with the presence of several small and big players. Prominent players in this market include Thermo Fisher Scientific Inc., BGI, GENEWIZ, Inc., GATC Biotech, Novogene Co., Ltd., QIAGEN, Integrated DNA Technologies, Inc., Illumina Inc., Agilent Technologies, Inc., Eurofins Scientific, F. Hoffmann-La Roche Ltd, Personalis Inc., GeneDx Inc., and Invitae Corporation
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Gene Panel Market to See Booming Future Scope 2021-2028 | Thermo Fisher Scientific, BGI, GENEWIZ, GATC Biotech appeared first on Gatorledger.
The article discusses the growth and future scope of the Gene Panel market from 2021 to 2028.
COVID-19 has disrupted supply chains but increased demand for gene panels in diagnosing related diseases.
Gene panels are used to assess multiple genes for mutations related to diseases like cancer and cardiomyopathy.
Explore more articles in the Research Reports category
